x
Breaking News
0

Biogen Inc (BIIB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Biogen Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
271.16 -3.48    -1.27%
14:21:10 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US09062X1037 
CUSIP: 09062X103
  • Volume: 136,465
  • Bid/Ask: 271.14 / 271.45
  • Day's Range: 271.12 - 275.11
START TRADING NOW
Biogen Inc 271.16 -3.48 -1.27%

BIIB Overview

 
Information about the Biogen Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close274.64
Day's Range271.12 - 275.11
Revenue11.53B
Open275
52 wk Range236.67 - 333.65
EPS15.95
Volume136,465
Market Cap58.26B
Dividend (Yield)0 (N/A)
Average Vol. (3m)1,618,966
P/E Ratio17.22
Beta0.79
1-Year Change20.18%
Shares Outstanding212,115,203
Next Earnings DateJul 25, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Buy Buy
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Buy Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Buy Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Harami Bullish 15 Current
Falling Three Methods 5H Current
Completed Patterns
Three Inside Up 5H 1 Jun 28, 2017 11:00AM
Falling Three Methods 30 1 Jun 29, 2017 09:30AM
Engulfing Bearish 1W 2 Jun 11, 2017

Biogen Inc News & Analysis

Biogen Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 271.16 271.14 271.45 136,465 -1.27% USD 14:21:10  
  Mexico 4,911.19 0.00 0.00 0 0.00% MXN 28/06  
  Switzerland 252.50 222.00 325.00 0 0% CHF 20/06  
  Xetra 240.00 237.00 238.40 121 +0.78% EUR 13:35:00  
  Berlin 238.53 237.52 238.28 0 -1.06% EUR 14:03:00  
  Frankfurt 238.28 237.54 238.25 21 -1.37% EUR 13:46:00  
  Stuttgart 240.77 237.65 238.09 0 -0.17% EUR 13:32:00  
  TradeGate 238.24 237.46 237.83 215 -1.16% EUR 14:02:00  
  Munich 241.29 237.50 238.30 10 +1.93% EUR 08:56:00  
  Vienna 239.380 0.000 0.000 0 0.00% EUR 28/06  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tesla 363.34 371.00 363.00 -7.90 -2.13% 1.63M 14:21:18  
  Apple 144.15 145.13 143.97 -1.68 -1.15% 5.98M 14:21:16  
  Spherix 3.6500 4.2500 2.8300 +1.7400 +91.10% 18.46M 14:21:08  
  Amazon.com 978.58 987.56 977.10 -11.75 -1.19% 829.68K 14:21:14  
  AMD 12.877 13.150 12.820 -0.353 -2.67% 20.29M 14:21:20  
  Bank of America 24.49 24.67 24.36 +0.61 +2.55% 43.63M 14:21:23  
  NVIDIA 147.79 150.72 147.17 -3.96 -2.61% 5.35M 14:21:28  
  Rite Aid 2.990 3.110 2.880 -0.940 -23.92% 85.26M 14:21:24  
  Facebook 151.21 152.50 151.10 -2.03 -1.32% 4.37M 14:21:30  
  JPMorgan 91.75 92.65 91.34 +1.93 +2.15% 7.92M 14:21:24  

Biogen Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

7400

Equity Type

ORD

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
Securities and Exchange Commission (United States) Start Trading

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
50%
Bearish
50%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest BIIB Comments

Rem Sizlak
Rem Sizlak Oct 12, 2016 3:28PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What the ****is happening to this stock ??? Dropping 1 to 2% per day since last week...
Blue Chip Trader Way
Blue Chip Trader Way Oct 04, 2016 3:59PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good company that is growing its numbers and efficiency continuously, considering the last periods(in 21st century).
Rem Sizlak
Rem Sizlak Oct 07, 2016 12:10PM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Agreed, but why do the EPVs start selling so much of their shares? Makes the stock drop non-stop these days...
Jp Gilson
Jp Gilson Aug 03, 2016 10:57AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy the rumor, sell the news
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google+
or
Sign up with Email